These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18084046)

  • 21. Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer.
    Pfisterer J; Vergote I; Du Bois A; Eisenhauer E; ; ;
    Int J Gynecol Cancer; 2005; 15 Suppl 1():36-41. PubMed ID: 15839957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.
    Kose MF; Meydanli MM; Tulunay G
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):437-43. PubMed ID: 16503860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage chemotherapy for ovarian carcinoma recurring during or after consolidation chemotherapy with paclitaxel.
    Miyoshi Y; Ueda Y; Morimoto A; Yokoyama T; Matsuzaki S; Kobayashi E; Kimura T; Yoshino K; Fujita M; Enomoto T; Kimura T
    Anticancer Res; 2011 Dec; 31(12):4613-7. PubMed ID: 22199338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer.
    Micha JP; Goldstein BH; Rettenmaier MA; Mattison J; Graham C; Birk CL; Brown JV
    Gynecol Oncol; 2004 Sep; 94(3):719-24. PubMed ID: 15350364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future directions in the chemotherapy of ovarian cancer.
    Ozols RF
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
    Bepler G; Dilling TJ; Wagner H; Hazelton T; Williams C; Chen DT; Greenberg H; Walsh F; Simon G; Tanvetyanon T; Chiappori A; Haura E; Stevens C
    J Thorac Oncol; 2011 Mar; 6(3):553-8. PubMed ID: 21289520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
    Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
    Lee M; Kim SW; Nam EJ; Cho H; Kim JH; Kim YT; Kim S
    Yonsei Med J; 2014 Nov; 55(6):1664-71. PubMed ID: 25323906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of chemoradiotherapy with carbon ions and the influence of p53 mutational status in the colorectal carcinoma cell line HCT 116.
    Adeberg S; Baris D; Habermehl D; Rieken S; Brons S; Weber KJ; Roth W; Debus J; Combs SE
    Tumori; 2014; 100(6):675-84. PubMed ID: 25688502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undifferentiated endometrial carcinoma of the uterus: marked effect of chemotherapy with tetrahydropyranyl-adriamycin, paclitaxel, and carboplatin.
    Hayashi M; Ueda Y; Takimoto T; Ohkura T
    Int J Gynecol Cancer; 2004; 14(2):388-94. PubMed ID: 15086745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel/carboplatin versus cyclophosphamide/carboplatin in peritoneal carcinomatosis of the ovary.
    Balat O
    Eur J Gynaecol Oncol; 2004; 25(2):195-6. PubMed ID: 15032280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab.
    Dohrmann T; Kutup A; Mahner S; Müller V; Jaenicke F; Izbicki JR; Vashist YK
    J Clin Oncol; 2013 Apr; 31(12):e208-10. PubMed ID: 23509305
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.
    Sehouli J; Stengel D; Oskay G; Blohmer J; Kaubitzsch S; Lichtenegger W;
    Onkologie; 2004 Feb; 27(1):58-64. PubMed ID: 15007250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advanced ovarian cancer with Sister Mary Joseph's nodule--a case report].
    Ohta S; Yamakawa Y; Hasegawa T; Tateno M; Matsui K
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):117-9. PubMed ID: 17220685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete response to radiation therapy in a patient with chemotherapy-resistant ovarian clear cell adenocarcinoma.
    Takai N; Utsunomiya H; Kawano Y; Nasu K; Narahara H; Miyakawa I
    Arch Gynecol Obstet; 2002 Dec; 267(2):98-100. PubMed ID: 12439556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
    Choi CH; Lee YY; Song TJ; Park HS; Kim MK; Kim TJ; Lee JW; Lee JH; Bae DS; Kim BG
    Cancer; 2011 May; 117(10):2104-11. PubMed ID: 21523722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.
    Hainsworth JD; Spigel DR; Clark BL; Shipley D; Thompson DS; Farley C; West-Osterfield K; Lane CM; Cescon T; Bury MJ; Greco FA
    Cancer J; 2010; 16(1):70-5. PubMed ID: 20164695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine and carboplatin in second-line ovarian cancer.
    Ozols RF
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S4-8. PubMed ID: 16143161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
    Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.